HYPOZALIX Trademark

Trademark Overview

On Thursday, December 22, 2011, a trademark application was filed for HYPOZALIX with the United States Patent and Trademark Office. The USPTO has given the HYPOZALIX trademark a serial number of 79110380. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 8, 2019. This trademark is owned by Biorganon SA. The HYPOZALIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely saliva substitute for the treatment of hyposialia or asialia (lack of saliva secretion)
hypozalix

General Information

Serial Number79110380
Word MarkHYPOZALIX
Filing DateThursday, December 22, 2011
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 8, 2019
Registration Number4181572
Registration DateTuesday, July 31, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements

Goods and ServicesPharmaceutical products, namely saliva substitute for the treatment of hyposialia or asialia (lack of saliva secretion)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiorganon SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameBiorganon SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameBiorganon SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, January 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 2, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, December 2, 2019INVALIDATION PROCESSED
Friday, November 8, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 8, 2019CANCELLED SECTION 71
Monday, July 31, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, September 6, 2016REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Tuesday, September 6, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, November 15, 2015INTERNATIONAL REGISTRATION RENEWED
Thursday, September 4, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 4, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 8, 2014NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 6, 2012NOTIFICATION PROCESSED BY IB
Friday, August 31, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 31, 2012FINAL DISPOSITION PROCESSED
Thursday, August 30, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 31, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTICE OF PUBLICATION
Tuesday, April 17, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, April 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 11, 2012ASSIGNED TO EXAMINER
Wednesday, April 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 10, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, April 9, 2012SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

hypozalix saliva asialia lack secretion hyposialia substitute products namely pharmaceutical treatment